Ulrich Lücking

3.5k total citations · 2 hit papers
34 papers, 2.6k citations indexed

About

Ulrich Lücking is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Ulrich Lücking has authored 34 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Ulrich Lücking's work include Synthesis and Catalytic Reactions (12 papers), Click Chemistry and Applications (9 papers) and Cancer-related Molecular Pathways (7 papers). Ulrich Lücking is often cited by papers focused on Synthesis and Catalytic Reactions (12 papers), Click Chemistry and Applications (9 papers) and Cancer-related Molecular Pathways (7 papers). Ulrich Lücking collaborates with scholars based in Germany, United Kingdom and United States. Ulrich Lücking's co-authors include Juan Alberto Sirvent, Steven V. Ley, Philip Lienau, Martina Schäfer, Gerhard Siemeister, Stuart L. Warriner, Antje M. Wengner, Robert A. Stockman, Dmitry M. Rudkevich and Dominik Mumberg and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Ulrich Lücking

33 papers receiving 2.6k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sulfoximines: A Neglected Opportunity in Medicinal Chemistry

2013 550 citations Ulrich Lücking Angewandte Chemie International Edition profile →
Neglected sulfur(vi) pharmacophores in drug discovery: exploration of novel chemical space by the interplay of drug design and method development

2019 277 citations Ulrich Lücking profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrich Lücking Germany	21	2.1k	868	264	190	137	34	2.6k
Benoı̂t Joseph France	25	1.6k 0.7×	822 0.9×	282 1.1×	57 0.3×	85 0.6×	95	2.3k
Peter G. Goekjian France	24	1.0k 0.5×	907 1.0×	126 0.5×	121 0.6×	38 0.3×	65	1.7k
Tao Lu China	33	2.1k 1.0×	1.3k 1.4×	330 1.3×	82 0.4×	52 0.4×	176	3.3k
Ji‐Wang Chern Taiwan	26	1.1k 0.5×	1.2k 1.4×	312 1.2×	55 0.3×	59 0.4×	116	2.2k
Atli Thorarensen United States	24	1.2k 0.6×	749 0.9×	156 0.6×	71 0.4×	24 0.2×	45	2.0k
Shino Manabe Japan	28	1.6k 0.7×	1.6k 1.9×	309 1.2×	31 0.2×	43 0.3×	114	2.4k
Ian R. Hardcastle United Kingdom	31	1.1k 0.5×	1.8k 2.1×	993 3.8×	67 0.4×	178 1.3×	81	3.1k
Jiancun Zhang China	25	1.5k 0.7×	631 0.7×	185 0.7×	54 0.3×	41 0.3×	68	2.3k
Chune Dong China	26	1.1k 0.5×	729 0.8×	208 0.8×	52 0.3×	65 0.5×	85	1.8k
Kenneth W. Bair United States	24	741 0.3×	1.4k 1.6×	645 2.4×	90 0.5×	65 0.5×	48	2.3k

Countries citing papers authored by Ulrich Lücking

Since Specialization

Citations

This map shows the geographic impact of Ulrich Lücking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Lücking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Lücking more than expected).

Fields of papers citing papers by Ulrich Lücking

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Lücking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Lücking. The network helps show where Ulrich Lücking may publish in the future.

Co-authorship network of co-authors of Ulrich Lücking

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Lücking. A scholar is included among the top collaborators of Ulrich Lücking based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Lücking. Ulrich Lücking is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lücking, Ulrich. (2022). New Opportunities for the Utilization of the Sulfoximine Group in Medicinal Chemistry from the Drug Designer's Perspective**. Chemistry - A European Journal. 28(56). e202201993–e202201993. 79 indexed citations

Briggs, Edward L., et al.. (2020). Synthesis of Highly Enantioenriched Sulfonimidoyl Fluorides and Sulfonimidamides by Stereospecific Sulfur–Fluorine Exchange (SuFEx) Reaction. Chemistry - A European Journal. 26(55). 12533–12538. 107 indexed citations

Lienau, Philip, et al.. (2020). Increasing Complexity: A Practical Synthetic Approach to Three‐Dimensional, Cyclic Sulfoximines and First Insights into Their in Vitro Properties. Chemistry - A European Journal. 26(19). 4378–4388. 26 indexed citations

Wengner, Antje M., Gerhard Siemeister, Ulrich Lücking, et al.. (2019). The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models. Molecular Cancer Therapeutics. 19(1). 26–38. 145 indexed citations

Wortmann, Lars, B. Lindenthal, Peter Muhn, et al.. (2019). Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo. Journal of Medicinal Chemistry. 62(22). 10321–10341. 12 indexed citations

Schäfer, Martina, et al.. (2018). Cover Feature: Exploration of Novel Chemical Space: Synthesis and in vitro Evaluation of N‐Functionalized Tertiary Sulfonimidamides (Chem. Eur. J. 37/2018). Chemistry - A European Journal. 24(37). 9166–9166. 2 indexed citations

Schäfer, Martina, et al.. (2018). Exploration of Novel Chemical Space: Synthesis and in vitro Evaluation of N‐Functionalized Tertiary Sulfonimidamides. Chemistry - A European Journal. 24(37). 9295–9304. 50 indexed citations

Schäfer, Martina, et al.. (2017). A New, Practical One‐Pot Synthesis of Unprotected Sulfonimidamides by Transfer of Electrophilic NH to Sulfinamides. Chemistry - A European Journal. 23(60). 15189–15193. 89 indexed citations

Lücking, Ulrich, Juan Alberto Sirvent, Donald Bierer, & Robert O. Webster. (2016). Palladium-Catalyzed Direct α-Arylation of p-Methoxybenzyl-Protected S,S-Dimethylsulfoximine. Synthesis. 49(5). 1024–1036. 11 indexed citations

10.

Lücking, Ulrich. (2013). Sulfoximine: Eine vernachlässigte Chance in der medizinischen Chemie. Angewandte Chemie. 125(36). 9570–9580. 125 indexed citations

11.

Lücking, Ulrich. (2013). Sulfoximines: A Neglected Opportunity in Medicinal Chemistry. Angewandte Chemie International Edition. 52(36). 9399–9408. 550 indexed citations breakdown →

12.

Lücking, Ulrich, Rolf Jautelat, Martin Krüger, et al.. (2013). The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (R)‐S‐Cyclopropyl‐S‐(4‐{[4‐{[(1R,2R)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2‐yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer. ChemMedChem. 8(7). 1067–1085. 152 indexed citations

13.

Siemeister, Gerhard, Ulrich Lücking, Antje M. Wengner, et al.. (2012). BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application. Molecular Cancer Therapeutics. 11(10). 2265–2273. 131 indexed citations

14.

Badock, Volker, et al.. (2009). Off‐Target Decoding of a Multitarget Kinase Inhibitor by Chemical Proteomics. ChemBioChem. 10(7). 1163–1174. 14 indexed citations

15.

Lücking, Ulrich, Gerhard Siemeister, Martina Schäfer, et al.. (2006). Macrocyclic Aminopyrimidines as Multitarget CDK and VEGF‐R Inhibitors with Potent Antiproliferative Activities. ChemMedChem. 2(1). 63–77. 38 indexed citations

16.

Lücking, Ulrich, Jian Chen, Dmitry M. Rudkevich, & Julius Rebek. (2001). A Self-Folding Metallocavitand. Journal of the American Chemical Society. 123(41). 9929–9934. 28 indexed citations

17.

Lücking, Ulrich, Fábio C. Tucci, Dmitry M. Rudkevich, & Julius Rebek. (2000). Self-Folding Cavitands of Nanoscale Dimensions. Journal of the American Chemical Society. 122(37). 8880–8889. 54 indexed citations

18.

Lücking, Ulrich, Dmitry M. Rudkevich, & Julius Rebek. (2000). Deep cavitands for anion recognition. Tetrahedron Letters. 41(49). 9547–9551. 26 indexed citations

19.

Baeschlin, Daniel K., et al.. (1998). Effiziente Synthese von Oligosacchariden: Totalsynthese eines Glycosylphosphatidyl‐ inosit‐Ankers aus Trypanosoma brucei. Angewandte Chemie. 110(24). 3609–3614. 17 indexed citations

20.

Baeschlin, Daniel K., et al.. (1998). Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei. Angewandte Chemie International Edition. 37(24). 3423–3428. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact